机译:转移性肾细胞癌患者中欣豫3周给药时间表的疗效和耐受性:三种情况报告
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
Department of Oncology Centre of Experimental and Clinical Oncology Florence University L.go G;
3-Week schedule; Metastatic renal cell carcinoma; Sunitinib;
机译:舒尼替尼3周给药方案在转移性肾细胞癌患者中的疗效和耐受性:三例报告
机译:低剂量,2周舒尼替尼给药后一周休息(2/1计划)对转移性肾细胞癌的疗效和耐受性:单中心经验(6例)
机译:开放标签,随机,多中心II期研究,通过剂量给药方案(剂量修改或剂量中断)评估舒尼替尼在晚期或转移性肾细胞癌患者中的疗效和耐受性:SURF试验的研究方案
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:低剂量2周舒尼替尼给药后一周休息(2/1计划)治疗转移性肾细胞癌的疗效和耐受性:单中心经验(6例)
机译:低剂量,2周舒尼替尼给药后一周休息(2/1计划)治疗转移性肾细胞癌的疗效和耐受性:单中心经验(6例)